Interpace Biosciences, Inc.
IDXG· OTC
IDXGInterpace Biosciences, Inc.
Filed Nov 10, 2011 · 10-Q · 41 days after period end · 0001054102-11-000069
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $36.07M | $35.97M |
| Net Income | -$202.00K | -$1.67M |
| EPS Diluted | -$0.01 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Interpace Biosciences, Inc. · CIK 1054102 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 10, 2011 · 41 d after period end
